Business Context and Reporting Period
Company: Central Garden & Pet Company (CENT/CENTA)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended December 27, 2025 (Fiscal Q1 2026)
Business Overview: A leading consumer goods company in the U.S. pet and garden industries, operating through two reportable segments: Pet and Garden. The company manufactures, markets, and distributes products including pet supplies, lawn and garden consumables, and animal health solutions.
Key Financial Metrics
| Metric (in thousands, except per share) | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $617,373 | $656,436 |
| Gross Profit | $190,608 | $195,699 |
| Gross Margin | 30.9% | 29.8% |
| Operating Income | $16,533 | $27,992 |
| Operating Margin | 2.7% | 4.3% |
| Net Income (GAAP) | $6,841 | $14,009 |
| Diluted EPS (GAAP) | $0.11 | $0.21 |
| Net Cash Used in Operating Activities | $(70,222) | $(68,832) |
| Cash and Cash Equivalents (Ending) | $721,150 | $618,020 |
| Total Debt (Long-term + Current) | $1,192,153 | $1,190,444 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.0% ($39.0 million) year-over-year. The Pet segment declined 2.7% due to portfolio optimization and shipment timing, while the Garden segment declined 12.0% driven by shipment timing, loss of distribution for two product lines, and exits from lower-margin live plant categories.
- Profitability Pressure: Operating income dropped 40.9% ($11.5 million) to $16.5 million. Despite a 110 basis point increase in gross margin (driven by productivity gains and mix shifts), this was offset by a $6.4 million increase in SG&A expenses.
- Facility Closure Charges: The company incurred approximately $7.7 million in charges related to its "Cost and Simplicity" program, including $7.2 million in the Garden segment and $0.5 million in the Pet segment for facility closures and severance.
- Segment Performance: The Pet segment remained profitable with operating income of $49.8 million. The Garden segment reported an operating loss of $9.7 million, compared to income of $2.4 million in the prior year, largely due to the aforementioned closure charges and sales declines.
- Acquisition Activity: The company acquired the U.S. assets of Champion USA LLC for approximately $57 million in cash to expand its livestock health portfolio.
Guidance, Outlook, and Risks
- Non-GAAP Performance: On a non-GAAP basis (excluding facility closure charges), operating income was $24.3 million and net income was $12.8 million ($0.21 diluted EPS), showing a smaller decline compared to GAAP results.
- Liquidity and Capital: The company maintains a $600 million asset-based revolving credit facility with approximately $545 million in net availability as of December 27, 2025. No borrowings were outstanding under this facility at period end. Management anticipates capital expenditures of approximately $50 million for fiscal 2026.
- Seasonality: The Garden segment is highly seasonal, with approximately 64% of its net sales typically occurring in the second and third fiscal quarters. Q1 results are not indicative of full-year performance.
- Risk Factors: Key risks include economic uncertainty, inflationary pressures, tariffs, supply chain disruptions, and the outcome of ongoing litigation (specifically the Nite Glow Industries case, where a $7.2 million judgment was entered but appealed).
- Share Repurchases: The company repurchased approximately 0.7 million shares of Class A common stock for $18.5 million during the quarter. Approximately $28.0 million remains authorized under the current repurchase program.
Investor Verification Checklist
- Facility Closure Impact: Verify the sustainability of the $7.7 million in one-time charges and the timeline for realizing cost savings from the "Cost and Simplicity" network optimization.
- Garden Segment Turnaround: Assess the impact of the 12% sales decline in the Garden segment and the effectiveness of the exit from lower-margin live plant categories on future profitability.
- Working Capital Trends: Monitor the $113 million increase in inventory and the $32 million increase in accounts receivable, which contributed to negative operating cash flow.
- Legal Contingency: Track the status of the appeal regarding the $7.2 million Nite Glow Industries judgment to determine potential future liabilities.
- Acquisition Integration: Evaluate the strategic fit and integration progress of the Champion USA LLC acquisition ($57 million) into the animal health portfolio.